sequencing-based diagnostics Feb 16, 2022 Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses Premium Feb 15, 2022 Adaptive Biotechnologies Revenues Rise 26 Percent in Q4, 57 Percent in 2021 May 11, 2021 Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development May 6, 2021 NantHealth Q1 Revenues Decline 11 Percent Apr 19, 2021 Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Mar 26, 2021 Rare Disease Screening Firm 3billion Closes $13M Series C Financing Mar 24, 2021 Twist Bioscience, Biotia Nab FDA EUA for Hybridization-Based NGS SARS-CoV-2 Assay Mar 16, 2021 Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China Feb 25, 2021 NantHealth Q4 Revenues Flat From Year Ago Feb 25, 2021 Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch Premium Feb 24, 2021 Adaptive Biotechnologies Q4 Revenues Rise 25 Percent Feb 16, 2021 Fulgent Genetics, BioIQ Partner on NGS-Based SARS-CoV-2 Variant Detection Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Jan 21, 2021 Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test Premium Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 7, 2021 Clear Labs, Integrated DNA Technologies Expand Partnership to Include COVID-19 Testing Dec 8, 2020 Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing Dec 3, 2020 Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing Dec 2, 2020 China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis Nov 24, 2020 Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform Load More Breaking News Rady Children's, PlumCare RWE Partner to Expand WGS-Based Newborn Screening Program to Greece Roche Gets CE Mark for New Version of Rapid Test for Antibodies Against SARS-CoV-2 Broader Market Drags 360Dx Top 30 Down in September Olive Diagnostics Nabs CE Mark for Optical Urinalysis Device Top Five Articles on 360Dx Last Week: Congress and VALID Act; FDA Updates EUA Policy; and More In Brief This Week: Becton Dickinson, Bionano, Yourgene, More
